Stifel cuts Janux Therapeutics target price to $34 from $35
JANX•Stifel cut its target price for Janux Therapeutics to $34 from $35.
Related News
Kinder Morgan expects 2026 adjusted EPS more than 13% above budget
KMI•
Anika Therapeutics Q3 revenue rises on commercial channel growth
ANIK•
Marti Technologies sets third-quarter results announcement
MRT•
Planet Fitness: Deutsche Bank raises target price to $58 from $54
PLNT•
NeoGenomics to participate in Stephens and Piper Sandler investor conferences
NEO•